ERIK MARTINEZ: Open Payments
NPI 1225531551 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 85 payments from 21 companies in 2025. Trend: 2023 $847 · 2024 $4,690 · 2025 $1,772
Food & beverage: $1,753Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $447 |
| ABBVIE INC. | 17 | $261 |
| LEO Pharma Inc. | 7 | $202 |
| Genentech USA, Inc. | 4 | $110 |
| Organon LLC | 8 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Arcutis Biotherapeutics, Inc. | 4 | $86 |
| Incyte Corporation | 3 | $61 |
| Galderma Laboratories, L.P. | 2 | $39 |
Products named: COSENTYX, XOLAIR, SKYRIZI, ANZUPGO, RINVOQ, VTAMA, Sotyktu, Zoryve.
Industry payments across AZ — which companies pay providers there.
